XECHEM SETTLES ANTITRUST LAWSUIT AGAINST BRISTOL-MEYERS SQUIBB FOR $4.2 MILLION

Xechem International, Inc. (OTC BB: XKEM) Xechem International announced today that it has settled its antitrust lawsuit against Bristol-Meyers Squibb Co. for $4.2 million. Court files reveal that the case against Bristol-Meyers, which was brought in federal district court in Chicago in 2003, was based on Xechem's allegations that Bristol-Meyers had engaged in anticompetitive practices relating to Xechem's efforts to manufacture and bring to market the drug paclitaxel, a generic equivalent of Bristol's cancer drug, TAXOL(R).

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051220005164&newsLang=en)